There's little scientific validation behind the multibillion supplement industry - users take pills based on arbitrary whim. Vitagene is building a precision medicine approach - tailoring vitamin regimens to the individual.
Illumina will provide business guidance, $100,000 in seed funding, lab space and access to its genomics tools to the four new startups in its new accelerator class.
At the Abarca Forward conference earlier this year, George Van Antwerp, managing director at Deloitte, discussed how social determinants of health and a personalized member experience can improve medication adherence and health outcomes.